期刊文献+

深部真菌感染的分离鉴定和药敏试验结果分析

Analysis of the Results of Isolation,Identification and Drug Sensitivity Tests of Yeast-like Fungi Infection
下载PDF
导出
摘要 目的了解我院162株酵母样真菌的分离鉴定、构成比及药敏试验结果。方法用血琼脂平板及沙氏培养基分离真菌,用酵母菌鉴定条和真菌药敏试验条对分离出的162株酵母样真菌进行鉴定和药敏试验。结果162株酵母样真菌感染以念珠菌属为主。其中白色念珠菌占69.75%;其次为光滑念珠占11.73%;热带念珠菌占8.64%;克柔念珠菌占3.70%;近平滑念珠菌占3.07%;丝状菌占1.85%;其他少见酵母样真菌占1.23%。162株酵母样真菌对氟胞嘧啶、两性霉素B、制霉菌素、伊曲康唑、益康唑、酮康唑、氟康唑的敏感率分别为97.6%、97.8%、96.7%、84.2%、71.6%、80.9%、58.62%。结论氟康唑的耐药率最高,达37.93%,氟胞嘧啶、两性霉素B及制霉菌素是治疗酵母样真菌感染的首选药物。加强真菌的分离鉴定和药敏监测非常重要,可指导临床合理用药。 Objective To understand the isolation and identification, composition and drug sensitivity tests of 162 yeast-like fungi in the hospital. Methods The 162 yeast-like fungi with the blood agar plate and Shashi medium fungi were separated, and then make identification and sensitivity test with the yeast identification and fungi sensitivity test were made. Results Candida was the mainly in the 162 yeast-like fungal infections. Candida albicans accounted for 69.75 percent, followed by Candida glabrata for 11.73 percent; tropical Candida accounted for 8.64 percent; Candida Krusei accounted for 3.70 percent; Candida parapsilosis accounted for 3.07 percent; filamentous fungus accounted for 1.85 percent; the other rare yeast-like fungus accounted for 1.23 percent. 162 yeast-like fungi on flucytosine,amphotericin-B, nystatin, itraconazole, econazole, ketoconazole,fluconazole sensitive rates were 97.6% and 97.8%, 96.7%,84.2%,71.6%,80.9%,58.62%. Conclusion Fluconazole resistance rate is up to 37.93 percent. Flucytosine amphotericin-B and nystatin are the best medicine of treatment for yeast-like fungal infections. Fungi's isolation identification and efficacy monitoring are all very important to guide clinical rational drug using.
作者 周梨 孔苏卫
出处 《中国现代医生》 2008年第20期13-14,22,共3页 China Modern Doctor
关键词 真菌 酵母菌 药敏结果分析 Fungus Yeast Drug sensitivity tests
  • 相关文献

参考文献10

二级参考文献18

  • 1谢灵,周贵民,吴坚.酵母菌对抗真菌药的耐药性[J].中华内科杂志,1995,34(4):266-266. 被引量:44
  • 2王文莉.念珠菌对唑类药物耐药现象的研究现状[J].国外医学(皮肤性病学分册),1996,22(2):86-89. 被引量:34
  • 3张正,赵素蕊,庞良锦,王贺,刘文芸,严薇.临床标本分离475株酵母样真菌调查分析[J].中华医学检验杂志,1996,19(5):267-269. 被引量:40
  • 4Edwards JE, Bodey GP, Bowden RA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infectious[J]. Clin Infect Dis, 1997,25:43-59.
  • 5National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility of yeast ; Approved standard M27A[ S]. Lancaster Avenue, villanova, pennsylvania: NCCLS, 1997.1-12.
  • 6Ptaller MA, Jones RV, Doern GV, et al. Bloodstream infectious due to candida species: SENTRY antimicrobial surveillance program in North America and Latin America[ J ]. Antimicrob Agents Chemother, 2000,44 :747-751.
  • 7Schwab U, Chemomas F, Larcom L, et al. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients [J ]. Diag Microbiol Infect Dis, 1997,29 : 11-17.
  • 8周贵民,中华医学检验杂志,1996年,19卷,301页
  • 9李仲兴,诊断细菌学,1992年,518页
  • 10Mizushima Y,Int Med,1996年,35卷,707页

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部